Fear extinction and BDNF: Translating animal models of PTSD to the clinic

Genes, Brain and Behavior

Volumn 11, Issue 5, 2012, Pages 503-512

  Andero, R ^a   Ressler, K J ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Anxiety; Brain derived neurotrophic factor; Depression; Fear; Neurotrophic factor; PTSD; TrkB

Indexed keywords

7,8 DIHYDROXYFLAVONE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CYCLOSERINE; ENDOCANNABINOID; HISTONE DEACETYLASE INHIBITOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR;

AMYGDALOID NUCLEUS; ANXIETY DISORDER; FEAR; GENE ACTIVATION; GENE EXPRESSION; GENETIC MANIPULATION; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LONG TERM POTENTIATION; MEMORY; MEMORY CONSOLIDATION; MOOD DISORDER; NERVE CELL PLASTICITY; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW;

ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; EXTINCTION, PSYCHOLOGICAL; FEAR; HUMANS; LEARNING; NEURONAL PLASTICITY; STRESS DISORDERS, POST-TRAUMATIC; TRANSLATIONAL MEDICAL RESEARCH;

ANIMALIA;

EID: 84863185677     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2012.00801.x     Document Type: Review

References (107)

1. Aid, T., Kazantseva, A., Piirsoo, M., Palm, K. & Timmusk, T. (2007) Mouse and rat BDNF gene structure and expression revisited. J Neurosci R 85, 525-535.
2. American Psychiatric Association. (2000) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR).American Psychiatric Association, Washington, DC.
3. Amstadter, A.B., Koenen, K.C., Ruggiero, K.J., Acierno, R., Galea, S., Kilpatrick, D.G. & Gelernter, J. (2009) Variant in RGS2 moderates posttraumatic stress symptoms following potentially traumatic event exposure. J Anxiety Disord 23, 369-373.
4. Andero, R., Heldt, S.A., Ye, K., Liu, X., Armario, A. & Ressler, K.J. (2011) Effect of 7, 8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. Am J Psychiatry 168, 163-172.
5. Andero, R., Daviu, N., Escorihuela, R.M., Nadal, R. & Armario, A. (2012) 7, 8-dihydroxyflavone, a TrkB receptor agonist, blocks long-term spatial memory impairment caused by immobilization stress in rats. Hippocampus 22, 399-408.
6. Aso, E., Ozaita, A., Valdizán, E.M., Ledent, C., Pazos, A., Maldonado, R. & Valverde, O. (2008) BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. J Neurochem 105, 565-572.
7. Bath, K.G., Jing, D.Q., Dincheva, I., Neeb, C.C., Pattwell, S.S., Chao, M.V., Lee, F.S. & Ninan, I. (2012) BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity. Neuropsychopharmacology 37, 1297-1304.
8. Berger, W., Mehra, A., Lenoci, M., Metzler, T.J., Otte, C., Tarasovsky, G., Mellon, S.H., Wolkowitz, O.M., Marmar, C.R. & Neylan, T.C. (2010) Serum brain-derived neurotrophic factor predicts responses to escitalopram in chronic posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 34, 1279-1284.
9. Binder, E.B., Bradley, R.G., Liu, W., Epstein, M.P., Deveau, T.C., Mercer, K.B., Tang, Y., Gillespie, C.F., Heim, C.M., Nemeroff, C.B., Schwartz, A.C., Cubells, J.F. & Ressler, K.J. (2008) Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299, 1291-1305.
10. Blugeot, A., Rivat, C., Bouvier, E., Molet, J., Mouchard, A., Zeau, B., Bernard, C., Benoliel, J.-J. & Becker, C. (2011) Vulnerability to depression: from brain neuroplasticity to identification of biomarkers. J Neurosci 31, 12889-12899.
11. Bredy, T.W. & Barad, M. (2008) The histone deacetylase inhibitor valproic acid enhances acquisition, extinction, and reconsolidation of conditioned fear. Learn Mem (Cold Spring Harbor, N.Y.) 15, 39-45.
12. Bredy, T.W., Wu, H., Crego, C., Zellhoefer, J., Sun, Y.E. & Barad, M. (2007) Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem 14, 268-276.
13. Bueller, J.A., Aftab, M., Sen, S., Gomez-Hassan, D., Burmeister, M. & Zubieta, J.-K. (2006) BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 59, 812-815.
14. Cao, L., Dhilla, A., Mukai, J., Blazeski, R., Lodovichi, C., Mason, C.A. & Gogos, J.A. (2007) Genetic modulation of BDNF signaling affects the outcome of axonal competition in vivo. Curr Biol 17, 911-921.
15. Chao, M.V. (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 4, 299-309.
16. Chen, Z.Y., Patel, P.D., Sant, G., Meng, C.X., Teng, K.K., Hempstead, B.L. & Lee, F.S. (2004) Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 24, 4401-4411.
17. Chen, Z.Y., Ieraci, A., Teng, H., Dall, H., Meng, C.X., Herrera, D.G., Nykjaer, A., Hempstead, B.L. & Lee, F.S. (2005) Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway. J Neurosci 25, 6156-6166.
18. Chen, Z.Y., Jing, D., Bath, K.G., Ieraci, A., Khan, T., Siao, C.J., Herrera, D.G., Toth, M., Yang, C., McEwen, B.S., Hempstead, B.L. & Lee, F.S. (2006) Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314, 140-143.
19. Chhatwal, J.P. & Ressler, K.J. (2007) Modulation of fear and anxiety by the endogenous cannabinoid system. CNS Spectr 12, 211-220.
20. Chhatwal, J.P., Stanek-Rattiner, L., Davis, M. & Ressler, K.J. (2006) Amygdala BDNF signaling is required for consolidation but not encoding of extinction. Nature Neurosci 9, 870-872.
21. Choi, D.C., Maguschak, K.A., Ye, K., Jang, S.-W., Myers, K.M. & Ressler, K.J. (2010a) Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear. ProcNatl Acad Sci USA 107, 2675-2680.
22. Choi, D.C., Rothbaum, B.O., Gerardi, M. & Ressler, K.J. (2010b)Pharmacological enhancement of behavioral therapy: focus on posttraumatic stress disorder. Curr Top Behav Neurosci 2, 279-299.
23. Cornelis, M.C., Nugent, N.R., Amstadter, A.B. & Koenen, K.C. (2010) Genetics of post-traumatic stress disorder: review and recommendations for genome-wide association studies. Curr Psychiatry Rep 12, 313-326.
24. Dell'osso, L., Carmassi, C., Del Debbio, A., Dell'osso, M.C., Bianchi, C., da Pozzo, E., Origlia, N., Domenici, L., Massimetti, G., Marazziti, D. & Piccinni, A. (2009) Brain-derived neurotrophic factor plasma levels in patients suffering from post-traumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 33, 899-902.
25. Devi, L. & Ohno, M. (2012) 7, 8-Dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Neuropsychopharmacology 37, 434-444.
26. D'Souza, D.C., Pittman, B., Perry, E. & Simen, A. (2009)Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans. Psychopharmacology 202, 569-578.
27. Egan, M.F., Kojima, M., Callicott, J.H., Goldberg, T.E., Kolachana, B.S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., Lu, B. & Weinberger, D.R. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257-269.
28. Ernfors, P., Lee, K.F. & Jaenisch, R. (1994) Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368, 147-150.
29. Frielingsdorf, H., Bath, K.G., Soliman, F., Difede, J., Casey, B.J. & Lee, F.S. (2010) Variant brain-derived neurotrophic factor Val66Met endophenotypes: implications for posttraumatic stress disorder. Ann N Y Acad Sci 1208, 150-157.
30. Fuchikami, M., Morinobu, S., Segawa, M., Okamoto, Y., Yamawaki, S., Ozaki, N., Inoue, T., Kusumi, I., Koyama, T., Tsuchiyama, K. & Terao, T. (2011) DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS ONE 6, e23881-e23881.
31. Gourley, S.L., Kedves, A.T., Olausson, P. & Taylor, J.R. (2009)A history of corticosterone exposure regulates fear extinction and cortical NR2B, GluR2/3, and BDNF. Neuropsychopharmacology 34, 707-716.
32. Greenwood, B.N., Strong, P.V., Foley, T.E., Thompson, R.S. & Fleshner, M. (2007) Learned helplessness is independent of levels of brain-derived neurotrophic factor in the hippocampus. Neuroscience 144, 1193-1208.
33. Guastella, A.J., Richardson, R., Lovibond, P.F., Rapee, R.M., Gaston, J.E., Mitchell, P. & Dadds, M.R. (2008) A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol Psychiatry 63, 544-549.
34. Hammack, S.E., Cheung, J., Rhodes, K.M., Schutz, K.C., Falls, W.A., Braas, K.M. & May, V. (2009) Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior. Psychoneuroendocrinology 34, 833-843.
35. Hauck, S., Kapczinski, F., Roesler, R., de Moura Silveira, E., Magalhães, P.V., Kruel, L.R.P., Schestatsky, S.S. & Ceitlin, L.H.F. (2010)Serum brain-derived neurotrophic factor in patients with trauma psychopathology. Prog Neuropsychopharmacol Biol Psychiatry 34, 459-462.
36. Heldt, S.A., Stanek, L., Chhatwal, J.P. & Ressler, K.J. (2007)Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry 12, 656-670.
37. Hetrick, S.E., Purcell, R., Garner, B. & Parslow, R. (2010)Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev CD007316.
38. Hofmann, S.G., Meuret, A.E., Smits, J.A.J., Simon, N.M., Pollack, M.H., Eisenmenger, K., Shiekh, M. & Otto, M.W. (2006)Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry 63, 298-304.
39. Jang, S.-W., Liu, X., Chan, C.B., France, S.A., Sayeed, I., Tang, W., Lin, X., Xiao, G., Andero, R., Chang, Q., Ressler, K.J. & Ye, K. (2010a) Deoxygedunin, a natural product with potent neurotrophic activity in mice. PLoS ONE 5, e11528-e11528.
40. Jang, S.-W., Liu, X., Yepes, M., Shepherd, K.R., Miller, G.W., Liu, Y., Wilson, W.D., Xiao, G., Blanchi, B., Sun, Y.E. & Ye, K. (2010b) A selective TrkB agonist with potent neurotrophic activities by 7, 8-dihydroxyflavone. Proc Natl Acad Sci USA 107, 2687-2692.
41. Kang, H. & Schuman, E.M. (1995) Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 267, 1658-1662.
42. Karpova, N.N., Pickenhagen, A., Lindholm, J., Tiraboschi, E., Kulesskaya, N., Agustsdottir, A., Antila, H., Popova, D., Akamine, Y., Sullivan, R., Hen, R., Drew, L.J. & Castren, E. (2011) Fear erasure in mice requires synergy between antidepressant drugs and extinction training. Science 334, 1731-1734.
43. Khaspekov, L.G., Brenz Verca, M.S., Frumkina, L.E., Hermann, H., Marsicano, G. & Lutz, B. (2004) Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity. Eur J Neurosci 19, 1691-1698.
44. Kidane, A.H., Roubos, E.W. & Jenks, B.G. (2008) Pituitary adenylate cyclase-activating polypeptide regulates brain-derived neurotrophic factor exon IV expression through the VPAC1 receptor in the amphibian melanotrope cell. Endocrinology 149, 4177-4182.
45. Kirtley, A. & Thomas, K.L. (2010) The exclusive induction of extinction is gated by BDNF. Learn Mem 17, 612-619.
46. Klein, R., Smeyne, R.J., Wurst, W., Long, L.K., Auerbach, B.A., Joyner, A.L. & Barbacid, M. (1993) Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell 75, 113-122.
47. Koenen, K.C., Lyons, M.J., Goldberg, J., Simpson, J., Williams, W.M., Toomey, R., Eisen, S.A., True, W.R., Cloitre, M., Wolfe, J. & Tsuang, M.T. (2003) A high risk twin study of combat-related PTSD comorbidity. Twin Res 6, 218-226.
48. Koenen, K.C., Hitsman, B., Lyons, M.J., Stroud, L., Niaura, R., McCaffery, J., Goldberg, J., Eisen, S.A., True, W. & Tsuang, M. (2006) Posttraumatic stress disorder and late-onset smoking in the Vietnam era twin registry. J Consult Clin Psychol 74, 186-190.
49. Koenen, K.C., Aiello, A.E., Bakshis, E., Amstadter, A.B., Ruggiero, K.J., Acierno, R., Kilpatrick, D.G., Gelernter, J. & Galea, S. (2009) Modification of the association between serotonin transporter genotype and risk of posttraumatic stress disorder in adults by county-level social environment. Am J Epidemiol 169, 704-711.
50. Koponen, E., Võikar, V., Riekki, R., Saarelainen, T., Rauramaa, T., Rauvala, H., Taira, T. & Castrén, E. (2004) Transgenic mice overexpressing the full-length neurotrophin receptor trkB exhibit increased activation of the trkB-PLCgamma pathway, reduced anxiety, and facilitated learning. Mol Cell Neurosci 26, 166-181.
51. Korte, M., Carroll, P., Wolf, E., Brem, G., Thoenen, H. & Bonhoeffer, T. (1995) Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92, 8856-8860.
52. Kushner, M.G., Kim, S.W., Donahue, C., Thuras, P., Adson, D., Kotlyar, M., McCabe, J., Peterson, J. & Foa, E.B. (2007)D-cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biol Psychiatry 62, 835-838.
53. Lattal, K.M., Barrett, R.M. & Wood, M.A. (2007) Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. Behav Neurosci 121, 1125-1131.
54. Lee, H., Kang, R., Lim, S., Paik, J., Choi, M., Lee, M. (2006) No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and post-traumatic stress disorder. Stress Health 22, 115-119.
55. Lemtiri-Chlieh, F. & Levine, E.S. (2010) BDNF evokes release of endogenous cannabinoids at layer 2/3 inhibitory synapses in the neocortex. J Neurophysiol 104, 1923-1932.
56. Li, C., Dabrowska, J., Hazra, R. & Rainnie, D.G. (2011)Synergistic activation of dopamine D1 and TrkB receptors mediate gain control of synaptic plasticity in the basolateral amygdala. PLoS ONE 6, e26065-e26065.
57. Lin, Y., Ter Horst, G.J., Wichmann, R., Bakker, P., Liu, A., Li, X. & Westenbroek, C. (2009) Sex differences in the effects of acute and chronic stress and recovery after long-term stress on stress-related brain regions of rats. Cereb Cortex 19, 1978-1989.
58. Liu, I.Y.C., Lyons, W.E., Mamounas, L.A. & Thompson, R.F. (2004) Brain-derived neurotrophic factor plays a critical role in contextual fear conditioning. J Neurosci 24, 7958-7963.
59. Liu, X., Chan, C.-B., Jang, S.-W., Pradoldej, S., Huang, J., He, K., Phun, L.H., France, S., Xiao, G., Jia, Y., Luo, H.R. & Ye, K. (in press) A synthetic 7, 8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect. J Med Chem (in press).
60. Lubin, F.D., Roth, T.L. & Sweatt, J.D. (2008) Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J Neurosci 28, 10576-10586.
61. Maddox, S.A. & Schafe, G.E. (2011) Epigenetic alterations in the lateral amygdala are required for reconsolidation of a Pavlovian fear memory. Learn Mem 18, 579-593.
62. Mahan, A.L. & Ressler, K.J. (2012) Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder. Trends Neurosci 35, 24-35.
63. Maison, P., Walker, D.J., Walsh, F.S., Williams, G. & Doherty, P. (2009) BDNF regulates neuronal sensitivity to endocannabinoids. Neurosci Lett 467, 90-94.
64. Marini, A.M., Rabin, S.J., Lipsky, R.H. & Mocchetti, I. (1998)Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartate. J Biol Chem 273, 29394-29399.
65. Marmigere, F., Givalois, L., Rage, F., Arancibia, S. & Tapia-Arancibia, L. (2003) Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats. Hippocampus 13, 646-655.
66. Massa, S.M., Yang, T., Xie, Y., Shi, J., Bilgen, M., Joyce, J.N., Nehama, D., Rajadas, J. & Longo, F.M. (2010) Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. J Clin Invest 120, 1774-1785.
67. Mehta, D., Gonik, M., Klengel, T., Rex-Haffner, M., Menke, A., Rubel, J., Mercer, K.B., Pütz, B., Bradley, B., Holsboer, F., Ressler, K.J., Müller-Myhsok, B. & Binder, E.B. (2011) Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch Gen Psychiatry 68, 901-910.
68. Mercer, K.B., Orcutt, H.K., Quinn, J.F., Fitzgerald, C.A., Conneely, K.N., Barfield, R.T., Gillespie, C.F. & Ressler, K.J. (2012) Acute and posttraumatic stress symptoms in a prospective gene x environment study of a University Campus Shooting. Arch Gen Psychiatry 69, 89-97.
69. Messaoudi, E., Ying, S.-W., Kanhema, T., Croll, S.D. & Bramham, C.R. (2002) Brain-derived neurotrophic factor triggers transcription-dependent, late phase long-term potentiation in vivo. J Neurosci 22, 7453-7461.
70. Milad, M.R. & Quirk, G.J. (2012) Fear extinction as a model for translational neuroscience: ten years of progress. Annu Rev Psychol 63, 129-151.
71. Minichiello, L. (2009) TrkB signalling pathways in LTP and learning. Nat Rev Neurosci 10, 850-860.
72. Molteni, R., Lipska, B.K., Weinberger, D.R., Racagni, G. & Riva, M.A. (2001) Developmental and stress-related changes of neurotrophic factor gene expression in an animal model of schizophrenia. Mol Psychiatry 6, 285-292.
73. Molteni, R., Calabrese, F., Chourbaji, S., Brandwein, C., Racagni, G., Gass, P. & Riva, M.A. (2010) Depression-prone mice with reduced glucocorticoid receptor expression display an altered stress-dependent regulation of brain-derived neurotrophic factor and activity-regulated cytoskeleton-associated protein. J Psychopharmacol 24, 595-603.
74. Musumeci, G. & Minichiello, L. (2011) BDNF-TrkB signalling in fear learning: from genetics to neural networks. Rev Neurosci 22, 303-315.
75. Myers, K.M. & Davis, M. (2007) Mechanisms of fear extinction. Mol Psychiatry 12, 120-150.
76. Myers, K.M., Carlezon, W.A. & Davis, M. (2011) Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacology 36, 274-293.
77. Ninan, I., Bath, K.G., Dagar, K., Perez-Castro, R., Plummer, M.R., Lee, F.S. & Chao, M.V. (2010) The BDNF Val66Met polymorphism impairs NMDA receptor-dependent synaptic plasticity in the hippocampus. J Neurosci 30, 8866-8870.
78. Norrholm, S.D. & Ressler, K.J. (2009) Genetics of anxiety and trauma-related disorders. Neuroscience 164, 272-287.
79. Otto, M.W., Tolin, D.F., Simon, N.M., Pearlson, G.D., Basden, S., Meunier, S.A., Hofmann, S.G., Eisenmenger, K., Krystal, J.H. & Pollack, M.H. (2010) Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry 67, 365-370.
80. Patterson, S.L., Abel, T., Deuel, T.A., Martin, K.C., Rose, J.C. & Kandel, E.R. (1996) Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16, 1137-1145.
81. Peters, J., Dieppa-Perea, L.M., Melendez, L.M. & Quirk, G.J. (2010) Induction of fear extinction with hippocampal-infralimbic BDNF. Science 328, 1288-1290.
82. Rakofsky, J.J., Ressler, K.J. & Dunlop, B.W. (2012) BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity. Mol Psychiatry 17, 22-35.
83. Rattiner, L.M., Davis, M., French, C.T. & Ressler, K.J. (2004a)Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. J Neurosci 24, 4796-4806.
84. Rattiner, L.M., Davis, M. & Ressler, K.J. (2004b) Differential regulation of brain-derived neurotrophic factor transcripts during the consolidation of fear learning. Learn Mem 11, 727-731.
85. Reichardt, L.F. (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361, 1545-1564.
86. Ressler, K.J., Rothbaum, B.O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L. & Davis, M. (2004) Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 61, 1136-1144.
87. Ressler, K.J., Mercer, K.B., Bradley, B., Jovanovic, T., Mahan, A., Kerley, K., Norrholm, S.D., Kilaru, V., Smith, A.K., Myers, A.J., Ramirez, M., Engel, A., Hammack, S.E., Toufexis, D., Braas, K.M., Binder, E.B. & May, V. (2011) Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 470, 492-497.
88. Sierra-Mercado, D., Padilla-Coreano, N. & Quirk, G.J. (2011)Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology 36, 529-538.
89. Skelton, K., Ressler, K.J., Norrholm, S.D., Jovanovic, T. & Bradley-Davino, B. (2012) PTSD and gene variants: new pathways and new thinking. Neuropharmacology 62, 628-37.
90. Smith, M.A., Makino, S., Kvetnansky, R. & Post, R.M. (1995)Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15, 1768-1777.
91. Soliman, F., Glatt, C.E., Bath, K.G., Levita, L., Jones, R.M., Pattwell, S.S., Jing, D., Tottenham, N., Amso, D., Somerville, L.H., Voss, H.U., Glover, G., Ballon, D.J., Liston, C., Teslovich, T., Van Kempen, T., Lee, F.S. & Casey, B.J. (2010) A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science 327, 863-866.
92. Spencer, J.L., Waters, E.M., Milner, T.A., Lee, F.S. & McEwen, B.S. (2010) BDNF variant Val66Met interacts with estrous cycle in the control of hippocampal function. Proc Natl Acad Sci USA 107, 4395-4400.
93. Storch, E.A., Murphy, T.K., Goodman, W.K., Geffken, G.R., Lewin, A.B., Henin, A., Micco, J.A., Sprich, S., Wilhelm, S., Bengtson, M. & Geller, D.A. (2010) A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry 68, 1073-1076.
94. Tabuchi, A., Nakaoka, R., Amano, K., Yukimine, M., Andoh, T., Kuraishi, Y. & Tsuda, M. (2000) Differential activation of brain-derived neurotrophic factor gene promoters I and III by Ca2+ signals evoked via L-type voltage-dependent and N-methyl-D-aspartate receptor Ca2+ channels. J Biol Chem 275, 17269-17275.
95. Takei, S., Morinobu, S., Yamamoto, S., Fuchikami, M., Matsumoto, T. & Yamawaki, S. (2011) Enhanced hippocampal BDNF/TrkB signaling in response to fear conditioning in an animal model of posttraumatic stress disorder. J Psychiatr Res 45, 460-468.
96. Valente, N.L.M., Vallada, H., Cordeiro, Q., Miguita, K., Bressan, R.A., Andreoli, S.B., Mari, J.J. & Mello, M.F. (2011) Candidate-gene approach in posttraumatic stress disorder after urban violence: association analysis of the genes encoding serotonin transporter, dopamine transporter, and BDNF. J Mol Neurosci 44, 59-67.
97. Wang, Z., Baker, D.G., Harrer, J., Hamner, M., Price, M. & Amstadter, A. (2011) The relationship between combat-related posttraumatic stress disorder and the 5-HTTLPR/rs25531 polymorphism. Depress Anxiety 28, 1067-1073.
98. Wilhelm, S., Buhlmann, U., Tolin, D.F., Meunier, S.A., Pearlson, G.D., Reese, H.E., Cannistraro, P., Jenike, M.A. & Rauch, S.L. (2008) Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry 165, 335-341; quiz 409.
99. Wu, D. (2005) Neuroprotection in experimental stroke with targeted neurotrophins. NeuroRx 2, 120-128.
100. Xu, B., Gottschalk, W., Chow, A., Wilson, R.I., Schnell, E., Zang, K., Wang, D., Nicoll, R.A., Lu, B. & Reichardt, L.F. (2000) The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB. J Neurosci 20, 6888-6897.
101. Yaka, R., He, D.Y., Phamluong, K. & Ron, D. (2003) Pituitary adenylate cyclase-activating polypeptide (PACAP(1-38)) enhances N-methyl-D-aspartate receptor function and brain-derived neurotrophic factor expression via RACK1. J Biol Chem 278, 9630-9638.
102. Yang, Y.L. & Lu, K.T. (2005) Facilitation of conditioned fear extinction by d-cycloserine is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase cascades and requires de novo protein synthesis in basolateral nucleus of amygdala. Neuroscience 134, 247-260.
103. Yasuda, S., Liang, M.H., Marinova, Z., Yahyavi, A. & Chuang, D.M. (2009) The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry 14, 51-59.
104. Ying, S.-W., Futter, M., Rosenblum, K., Webber, M.J., Hunt, S.P., Bliss, T.V.P. & Bramham, C.R. (2002) Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J Neurosci 22, 1532-1540.
105. Yu, H., Wang, Y., Pattwell, S., Jing, D., Liu, T., Zhang, Y., Bath, K.G., Lee, F.S. & Chen, Z.-Y. (2009) Variant BDNF Val66Met polymorphism affects extinction of conditioned aversive memory. J Neurosci 29, 4056-4064.
106. Zhang, H., Ozbay, F., Lappalainen, J., Kranzler, H.R., van Dyck, C.H., Charney, D.S., Price, L.H., Southwick, S., Yang, B.-Z., Rasmussen, A. & Gelernter, J. (2006) Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am J Med Genet B Neuropsychiatr Genet 141B, 387-393.
107. Zink, M., Otto, C., Zörner, B., Zacher, C., Schütz, G., Henn, F.A. & Gass, P. (2004) Reduced expression of brain-derived neurotrophic factor in mice deficient for pituitary adenylate cyclase activating polypeptide type-I-receptor. Neuroscience Lett 360, 106-108.